SKYSTAR BIO-PHARMA CO's ticker is SKBI and the CUSIP is 830884300. A total of 1 filers reported holding SKYSTAR BIO-PHARMA CO in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $8,000 | -46.7% | 15,900 | 0.0% | 0.00% | – |
Q3 2015 | $15,000 | -64.3% | 15,900 | 0.0% | 0.00% | – |
Q2 2015 | $42,000 | -40.0% | 15,900 | 0.0% | 0.00% | – |
Q1 2015 | $70,000 | 0.0% | 15,900 | 0.0% | 0.00% | – |
Q4 2014 | $70,000 | +4.5% | 15,900 | 0.0% | 0.00% | – |
Q3 2014 | $67,000 | -42.7% | 15,900 | 0.0% | 0.00% | – |
Q2 2014 | $117,000 | +37.6% | 15,900 | 0.0% | 0.00% | – |
Q1 2014 | $85,000 | +51.8% | 15,900 | 0.0% | 0.00% | – |
Q4 2013 | $56,000 | -39.8% | 15,900 | 0.0% | 0.00% | – |
Q3 2013 | $93,000 | +389.5% | 15,900 | 0.0% | 0.00% | – |
Q2 2013 | $19,000 | – | 15,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 147,926 | $141,000 | 0.01% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 15,900 | $15,000 | 0.00% |
Renaissance Technologies | 52,300 | $50,000 | 0.00% |
UBS Group AG | 3,304 | $3,000 | 0.00% |
Walleye Trading LLC | 200 | $0 | 0.00% |
Citadel Advisors | 18,296 | $17,000 | 0.00% |
HighTower Advisors, LLC | 22,845 | $22,000 | 0.00% |
Tower Research Capital LLC (TRC) | 181 | $0 | 0.00% |
MORGAN STANLEY | 11,593 | $11,000 | 0.00% |
BlackRock Institutional Trust Company, N.A. | 175,708 | $167,000 | 0.00% |